Press release
Stress urinary incontinence Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | Innovacell Biotechnologie GmbH, Versameb AG, Taiho Pharmaceutical, Cook MyoSi
Stress urinary incontinence Clinical Trials
According to DelveInsight, the Stress Urinary Incontinence (SUI) pipeline includes over 10 leading companies actively developing more than 10 therapeutic candidates for the treatment of SUI.
Stress urinary incontinence Overview:
Stress Urinary Incontinence (SUI) is a prevalent and often distressing condition characterized by the involuntary leakage of urine during activities that increase abdominal pressure, such as coughing, sneezing, or exercising. It predominantly affects women, with factors such as childbirth, menopause, and weakened pelvic floor muscles contributing to its development. SUI can have a significant impact on daily life, causing embarrassment, social withdrawal, and diminished self-confidence.
The causes of SUI are multifactorial, involving various anatomical, physiological, and functional impairments. Key factors include weakness of the bladder neck and urethra, often due to pelvic floor muscle weakness and urethral sphincter dysfunction. Urethral hypermobility, in which the bladder neck and urethra shift out of place under pressure, further aggravates the condition. Additionally, inadequate urethral support and neuromuscular or mechanical dysfunction of the striated urethral sphincter contribute to urine leakage. Understanding these underlying mechanisms is crucial for effective treatment and management of SUI.
Request for a detailed insights report on Stress urinary incontinence pipeline insights [https://www.delveinsight.com/report-store/stress-urinary-incontinence-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
"Stress urinary incontinence Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Stress urinary incontinence Therapeutics Market.
Key Takeaways from the Stress urinary incontinence Pipeline Report
*
DelveInsight's Stress Urinary Incontinence (SUI) pipeline report highlights an active landscape, with over 10 companies developing more than 10 therapeutic candidates for SUI treatment.
*
Key players-including Innovacell Biotechnologie GmbH, Versameb AG, Taiho Pharmaceutical, Cook MyoSite, Mapi Pharma, and others-are exploring new therapies aimed at improving the SUI treatment landscape. Notable pipeline candidates in various stages of development include VMB-100, ICES13, among others.
*
In May 2024, Watkins-Conti received FDA 510(k) clearance for Yoni.Fit, a non-surgical, self-care device designed to manage SUI in women. Made entirely from medical-grade silicone, Yoni.Fit provides an innovative, non-invasive option for SUI management.
Stress urinary incontinence Pipeline Analysis
The report provides insights into:
*
The report provides detailed insights into the key companies that are developing therapies in the Stress urinary incontinence Market.
*
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Stress urinary incontinence treatment.
*
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Stress urinary incontinence market.
Download our free sample page report on Stress urinary incontinence pipeline insights [https://www.delveinsight.com/sample-request/stress-urinary-incontinence-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Stress urinary incontinence Emerging Drugs
*
ICES13: Innovacell Biotechnologie GmbH
*
VMB-100: Versameb AG
Stress urinary incontinence Companies
Over 10 leading companies are actively developing therapies for Stress Urinary Incontinence, with Innovacell Biotechnologie GmbH having a drug candidate that has reached the most advanced stage of development, Phase III.
DelveInsight's report covers around 10+ products under different phases of clinical development like
*
Late stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I) along with the details of
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
Stress urinary incontinence pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
*
Intravenous
*
Subcutaneous
*
Oral
*
Intramuscular
Stress urinary incontinence Products have been categorized under various Molecule types such as
*
Monoclonal antibody
*
Small molecule
*
Peptide
Download Sample Pages to Get an in-depth Assessment of the Emerging Stress urinary incontinence Therapies and Key Companies: Stress urinary incontinence Clinical Trials and advancements [https://www.delveinsight.com/report-store/stress-urinary-incontinence-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Stress urinary incontinence Pipeline Therapeutic Assessment
- Stress urinary incontinence Assessment by Product Type
- Stress urinary incontinence By Stage
- Stress urinary incontinence Assessment by Route of Administration
- Stress urinary incontinence Assessment by Molecule Type
Download Stress urinary incontinence Sample report to know in detail about the Stress urinary incontinence treatment market @ Stress urinary incontinence Therapeutic Assessment [https://www.delveinsight.com/sample-request/stress-urinary-incontinence-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Table of Content
1. Report Introduction
2. Executive Summary
3. Stress urinary incontinence Current Treatment Patterns
4. Stress urinary incontinence - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Stress urinary incontinence Late-Stage Products (Phase-III)
7. Stress urinary incontinence Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Stress urinary incontinence Discontinued Products
13. Stress urinary incontinence Product Profiles
14. Stress urinary incontinence Key Companies
15. Stress urinary incontinence Key Products
16. Dormant and Discontinued Products
17. Stress urinary incontinence Unmet Needs
18. Stress urinary incontinence Future Perspectives
19. Stress urinary incontinence Analyst Review
20. Appendix
21. Report Methodology
Request the Sample PDF to Get Detailed Insights About the Stress urinary incontinence Pipeline Reports Offerings [https://www.delveinsight.com/report-store/stress-urinary-incontinence-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=stress-urinary-incontinence-clinical-trials-companies-therapeutic-assessment-therapies-treatment-algorithm-pipeline-innovacell-biotechnologie-gmbh-versameb-ag-taiho-pharmaceutical-cook-myosi]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stress urinary incontinence Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | Innovacell Biotechnologie GmbH, Versameb AG, Taiho Pharmaceutical, Cook MyoSi here
News-ID: 4162673 • Views: …
More Releases from ABNewswire
Frish Law Group APLC Provides Steadfast Personal Injury Advocacy in Hollywood Hi …
Los Angeles, CA - August 28, 2025 - In the heart of Los Angeles, traffic collisions, workplace accidents, and unexpected injuries can disrupt lives in an instant. For many residents of Hollywood Hills and Central LA, Frish Law Group, APLC has become a reliable source of legal support, offering compassionate guidance and effective representation when it matters most.
The firm is known not only for its courtroom skill but also for…
Frish Law Group APLC Highlights Dedication to Personal Injury Representation in …
Woodland Hills, CA - August 28, 2025 - For families in Woodland Hills, the days and weeks after an accident often come with medical appointments, insurance calls, and overwhelming uncertainty. During these moments, Frish Law Group, APLC has become a dependable ally, guiding injury victims through complex legal challenges and toward fair compensation.
The firm has developed a strong reputation in Los Angeles County by focusing on the details that matter…
Primary Biliary Cholangitis Clinical Trials, Companies, Therapeutic Assessment, …
DelveInsight's, "Primary Biliary Cholangitis (PBC)- Pipeline Insight, 2025" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Primary Biliary Cholangitis (PBC) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
According to DelveInsight, the Primary Biliary Cholangitis…
Primary Hyperoxaluria Clinical Trials, Companies, Therapeutic Assessment, Therap …
DelveInsight's, "Primary Hyperoxyaluria - Pipeline Insight, 2025" report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Primary Hyperoxyaluria pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
According to DelveInsight, the Primary Hyperoxaluria pipeline features over 6…
More Releases for Stress
Leading Element Driving Change in the Stress Toy Market in 2025: Rising Stress A …
What Is the Estimated Market Size and Growth Rate for the Stress Toy Market?
In recent years, there has been a significant expansion in the stress toy market. The market, which was valued at $5.52 billion in 2024, is projected to increase to $5.88 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.6%. Several factors have contributed to growth during this historical period, including a higher incidence of…
Key Driver Reshaping the Stress Tracking Devices Market in 2025: Rising Stress-R …
"What Are the Projections for the Size and Growth Rate of the Stress Tracking Devices Market?
The market size for stress tracking devices has seen significant expansion in the past few years. Projected growth is from $3.14 billion in 2024 to $3.43 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 9.3%. The key factors that have contributed to growth over the historical period include the upsurge in stress-related…
Stress Testing Solutions Market Exploring Opportunities in Macroprudential Stres …
Increase in demand for mobile applications with advanced features is expected to drive the stress testing solutions market considerably in next few years. In addition, factors such as rise in adoption of mobile devices, need to ensure systems can handle extreme workloads, and adoption of test automation services are expected to majorly drive growth of the market. However, data management & data quality issues and uncertainties about easy availability of…
Stress Management 2023
Globally, the COVID-19 pandemic affected not only the financial status but also the mental health of the individuals drastically which increased the stress management market to USD 18,700.9 million and expected to increase at a CAGR of 3.8% during the forecast period. Globally, 10% of the children encounter any least one of the mental disorders. The preliminary treatment could be discussing the issue with the cherished circle, whereas professional…
Agrow Plant Stress Products
ReportsWorldwide has announced the addition of a new report title Agrow Plant Stress Products 2016 to its growing collection of premium market research reports.
Abiotic stresses such as heat, cold and drought prevent crops from reaching their full potential productivity. Plant stress products are a new category, increasing the tolerance of crop plants to these and other adverse environments. They span conventional pesticides with ‘crop enhancement’ or ‘plant health’ promoting properties,…
National Stress Awareness Day
National Stress Awareness Day is on Wednesday 5th November 2014. Relaxa is offering employee stress & wellbeing health promotion packages starting at £255 on or around this date - incorporating a range of stress & wellbeing activities for your staff.
There are 9 cost-effective stress and wellbeing promotion packages available below:
1) Stress Health Promotion Package 1 - £255.00+vat
2) Stress Health Promotion Package 2 - £399.00+vat
3) Stress Health Promotion Package 3…
